University of North Carolina-School of Medicine: Zylka Lab Awarded $6.1M From NIH to Develop CRISPR/Cas9 Gene Therapy for Angelman Syndrome
September 21, 2019
September 21, 2019
CHAPEL HILL, North Carolina, Sept. 21 [TNSgrantsresearch] -- The University of North Carolina's School of Medicine issued the following news release:
* * *
- Mark Zylka, PhD, director of the UNC Neuroscience Center, was awarded NIH funding for two 5-year projects, one jointly with Ben Philpot, PhD, to develop new knowledge with the potential to advance treatments for neurodevelopmental disorders.
* * *
The National Institutes of Health have awa . . .
* * *
- Mark Zylka, PhD, director of the UNC Neuroscience Center, was awarded NIH funding for two 5-year projects, one jointly with Ben Philpot, PhD, to develop new knowledge with the potential to advance treatments for neurodevelopmental disorders.
* * *
The National Institutes of Health have awa . . .